145 related articles for article (PubMed ID: 36202068)
1. Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
Liu W; Ji T; Zhang C; Zhou Q; Bao Z
Oral Oncol; 2022 Nov; 134():106129. PubMed ID: 36202068
[TBL] [Abstract][Full Text] [Related]
2. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma.
Kumari S; Mishra S; Anand N; Hadi R; Rastogi M; Husain N
Pathol Res Pract; 2023 Jun; 246():154489. PubMed ID: 37150134
[TBL] [Abstract][Full Text] [Related]
3. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract][Full Text] [Related]
5. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
6. Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma.
Kowal-Wisniewska E; Jaskiewicz K; Bartochowska A; Kiwerska K; Ustaszewski A; Gorecki T; Giefing M; Paluszczak J; Wierzbicka M; Jarmuz-Szymczak M
Sci Rep; 2024 Jan; 14(1):2251. PubMed ID: 38278927
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
8. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested.
Ji X; Guan C; Jiang X; Li H
Oncotarget; 2016 Nov; 7(48):80019-80032. PubMed ID: 27683120
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation biomarkers discovered
Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
16. The difficult "childhood era" of the liquidbiopsy as a diagnostic method in head and neckcancer patients.
Wierzbicka M; Bartochowska A
Otolaryngol Pol; 2023 Sep; 77(5):43-46. PubMed ID: 38032329
[TBL] [Abstract][Full Text] [Related]
17. Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis.
Zhou X; Cheng Z; Dong M; Liu Q; Yang W; Liu M; Tian J; Cheng W
Nat Commun; 2022 Dec; 13(1):7694. PubMed ID: 36509772
[TBL] [Abstract][Full Text] [Related]
18. Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma.
Verma T; Kumari S; Mishra S; Rastogi M; Tiwari V; Agarwal GR; Anand N; Husain N
Indian J Pathol Microbiol; 2020; 63(4):521-526. PubMed ID: 33154299
[TBL] [Abstract][Full Text] [Related]
19. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]